Stockreport

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

CVRx, Inc.  (CVRX) 
PDF MINNEAPOLIS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today the presentation of new r [Read more]